Key facts
- Notable investors include Chris Adelsbach.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Biomorphic Ai
- ·The full record, as it builds
Funding rounds
No funding rounds for Biomorphic Ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biomorphic Ai
Developer of a self-driving stem cell differentiation platform designed to automate and optimize the conversion of stem cells into targeted cell types. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2023
- Website
- biomorphic-ai.com/
- Ownership
- Privately Held (backing)
Biomorphic Ai doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biomorphic Ai shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biomorphic Ai in its N-PORT filings yet. We sweep new filings monthly.